# A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

> clinical trial · VERIFIED · 2026-07-06

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Moderately to Severely Active Crohns Disease

- Company: Hoffmann-La Roche
- Sector: Moderately to Severely Active Crohns Disease
- Primary source: https://clinicaltrials.gov/study/NCT06819891

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.